MX2022007019A - Producto oral que contiene un canabinoide. - Google Patents

Producto oral que contiene un canabinoide.

Info

Publication number
MX2022007019A
MX2022007019A MX2022007019A MX2022007019A MX2022007019A MX 2022007019 A MX2022007019 A MX 2022007019A MX 2022007019 A MX2022007019 A MX 2022007019A MX 2022007019 A MX2022007019 A MX 2022007019A MX 2022007019 A MX2022007019 A MX 2022007019A
Authority
MX
Mexico
Prior art keywords
cannabinoid
oral product
products
oral
emulsion
Prior art date
Application number
MX2022007019A
Other languages
English (en)
Inventor
Anthony Richard Gerardi
Steven Lee Alderman
Thomas H Poole
Original Assignee
Nicoventures Trading Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoventures Trading Ltd filed Critical Nicoventures Trading Ltd
Priority claimed from PCT/IB2020/061341 external-priority patent/WO2021116824A1/en
Publication of MX2022007019A publication Critical patent/MX2022007019A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La divulgación proporciona productos sólidos configurados para uso oral y un proceso para preparar tales productos orales sólidos. Los productos contienen una emulsión que incluye una fase continua y una fase dispersa. La emulsión incluye al menos un canabinoide.
MX2022007019A 2019-12-09 2020-12-02 Producto oral que contiene un canabinoide. MX2022007019A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962945487P 2019-12-09 2019-12-09
PCT/IB2020/061341 WO2021116824A1 (en) 2019-12-09 2020-12-02 Oral product comprising a cannabinoid

Publications (1)

Publication Number Publication Date
MX2022007019A true MX2022007019A (es) 2022-08-15

Family

ID=76316330

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022007019A MX2022007019A (es) 2019-12-09 2020-12-02 Producto oral que contiene un canabinoide.

Country Status (6)

Country Link
US (1) US20210177037A1 (es)
EP (1) EP4072518A1 (es)
JP (1) JP2023505357A (es)
AU (1) AU2020401471A1 (es)
CA (1) CA3160595A1 (es)
MX (1) MX2022007019A (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023002195A1 (en) * 2021-07-22 2023-01-26 Nicoventures Trading Limited Methods of preparing compositions comprising a constituent, derivative or extract of cannabis
AU2022315867A1 (en) * 2021-07-22 2024-01-25 Nicoventures Trading Limited Compositions comprising a constituent, derivative or extract of cannabis
CA3224625A1 (en) * 2021-07-22 2023-01-26 Steven Alderman Constituent, derivative or extract of cannabis in amorphous form
US20230217978A1 (en) * 2022-01-07 2023-07-13 Bright Green Corporation Palatable blended composition having cannabis oil

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2444641T3 (es) * 2001-02-14 2014-02-26 Gw Pharma Limited Formulaciones líquidas para pulverización para liberación bucal de cannabinoides
US8616221B2 (en) * 2007-02-28 2013-12-31 Philip Morris Usa Inc. Oral pouch product with flavored wrapper
US8124147B2 (en) * 2007-07-16 2012-02-28 Philip Morris Usa Inc. Oral pouch products with immobilized flavorant particles
US9167847B2 (en) * 2009-03-16 2015-10-27 Philip Morris Usa Inc. Production of coated tobacco particles suitable for usage in a smokeless tobacoo product
CN107530318A (zh) * 2015-03-02 2018-01-02 阿福金制药有限责任公司 用大麻素的局部区域神经影响性疗法
US20180271139A1 (en) * 2017-03-22 2018-09-27 Swedish Match North Europe Ab Oral pouched product having a rectangular shape
EP3716945A4 (en) * 2017-11-30 2021-04-07 Canopy Growth Corporation LIQUID DOSAGE FORMS, METHODS OF PREPARATION AND USE
WO2019135224A1 (en) * 2018-01-03 2019-07-11 Icdpharma Ltd. Taste-enhanced cannabinoid submicron emulsion syrup compositions
US11013715B2 (en) * 2018-07-19 2021-05-25 Vertosa, Inc. Nanoemulsion hydrophobic substances
US20210068447A1 (en) * 2019-09-11 2021-03-11 R. J. Reynolds Tobacco Company Pouched products with enhanced flavor stability
US11883527B2 (en) * 2019-12-09 2024-01-30 Nicoventures Trading Limited Oral composition and method of manufacture

Also Published As

Publication number Publication date
AU2020401471A1 (en) 2022-07-07
US20210177037A1 (en) 2021-06-17
CA3160595A1 (en) 2021-06-17
EP4072518A1 (en) 2022-10-19
JP2023505357A (ja) 2023-02-08

Similar Documents

Publication Publication Date Title
MX2022007019A (es) Producto oral que contiene un canabinoide.
MY186296A (en) Novel promoter and use thereof
EP3932230A4 (en) AEROSOL PRODUCT, PROCESS FOR ITS PRODUCTION AND ITS APPLICATION
EP3792236A4 (en) METHOD FOR PREPARING 1,2-DIFLUOROETHYLENE AND/OR 1,1,2-TRIFLUOROETHANE
EP3624020A4 (en) CALCULATION PROCEDURES AND RELATED PRODUCTS
EP3858007A4 (en) METHODS, DEVICES AND COMPUTER SOFTWARE PRODUCTS FOR RADIO PAGING
EP3804546A4 (en) AEROSOL GENERATION EQUIPMENT
EP3840617A4 (en) CANNABINOID CONSUMER PRODUCTS SYSTEMS, DEVICE AND METHOD
EP3792852A4 (en) PRODUCT RETURN/REPLACEMENT SYSTEM, PRODUCT RETURN/REPLACEMENT SERVER AND PRODUCT RETURN/REPLACEMENT DEVICE
AU2014378631A1 (en) Device and method for co-metering
MX2021002367A (es) Productos de papel aislado y repulpable, metodos para fabricarlos y usarlos.
EP3776200A4 (en) DISPLAY METHOD, COMPUTER PRODUCT AND DISPLAY DEVICE
PT3820300T (pt) Processo para a obtenção de produtos da indústria alimentar e/ou de rações para animais a partir de insetos e fase sólida obtida a partir de insetos
MX2016009720A (es) Sistema dispensador para productos de papel sanitario.
MX2018006843A (es) Uso de un material para el envasado de cosmeticos y sistema dispensador de un producto presurizado, que contiene al menos una parte de, o que incluye dicho material.
EP3817586A4 (en) VAPORIZER AND AEROSOL GENERATING APPARATUS COMPRISING THE SAME
MX2019000986A (es) Producto alimenticio fortificado con proteinas.
AU2017260386A1 (en) Coated food products
EP3927548A4 (en) PRINTING PROCESS AND ASSOCIATED PRODUCT
EP3835427A4 (en) PROCESS FOR GENERATION OF 3,5-DIHYDROXY-4-METHOXYBENZYL ALCOHOL FROM PLANKTON
EP3740929A4 (en) SYSTEM AND METHOD FOR CALCULATING THE EXECUTABLE PRICE OF A PAIR OF CRYPTOCURRENCY PRODUCTS
EP3881256A4 (en) SYSTEM, METHOD AND DEVICE FOR GENERATING TOKENIZED IMAGES
EP3772970A4 (en) PROTECTIVE FEED COMPOSITION FOR MEAT, MEAT PRODUCTS AND DAIRY PRODUCTS
EP3815557A4 (en) AEROSOL GENERATION PRODUCT, APPARATUS AND SYSTEM
EP4053753A4 (en) OPERATING EQUIPMENT AND ASSOCIATED PRODUCT